NRX Pharmaceuticals, Inc. (NRXP) Operating cash flow 2018–2025
NRX Pharmaceuticals, Inc. (NRXP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.1MFY2025 · since FY2018: -$473,187 → -$14.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.1M | -32.7% |
| FY2024 | -$10.6M | +50.9% |
| FY2023 | -$21.7M | +45.5% |
| FY2022 | -$39.8M | -5.4% |
| FY2021 | -$37.7M | -1564.6% |
| FY2020 | -$2.3M | -185.7% |
| FY2019 | -$792,731 | -67.5% |
| FY2018 | -$473,187 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRXP financial trends
NRXP RevenueNRXP Net incomeNRXP Net marginNRXP Gross profitNRXP Gross marginNRXP Operating incomeNRXP Operating marginNRXP Free cash flowNRXP Capital expendituresNRXP Return on equityNRXP Stock buybacksNRXP Dividends paidNRXP Total assetsNRXP Total liabilitiesNRXP Shareholders’ equityNRXP overview →